Macquarie Group
LEGN icon

Macquarie Group’s Legend Biotech LEGN Stock Holding History

Macquarie Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Sell
4,155
-1,941
-32% -$52.4K ﹤0.01% 800
2026
Q1 		$110K Hold
6,096
– – ﹤0.01% 777
2025
Q4 		$133K Buy
6,096
+2,267
+59% +$64.9K ﹤0.01% 800
2025
Q3 		$125K Buy
3,829
+1,821
+91% +$67.2K ﹤0.01% 1515
2025
Q2 		$70.9K Sell
2,008
-3,341
-62% -$108K ﹤0.01% 1583
2025
Q1 		$181K Sell
5,349
-1,538
-22% -$55.2K ﹤0.01% 1537
2024
Q4 		$224K Hold
6,887
– – ﹤0.01% 1507
2024
Q3 		$335K Hold
6,887
– – ﹤0.01% 1516
2024
Q2 		$305K Hold
6,887
– – ﹤0.01% 1521
2024
Q1 		$387K Hold
6,887
– – ﹤0.01% 1468
2023
Q4 		$414K Buy
6,887
+1,283
+23% +$81.3K ﹤0.01% 1491
2023
Q3 		$377K Buy
5,604
+712
+15% +$49.5K ﹤0.01% 1466
2023
Q2 		$338K Hold
4,892
– – ﹤0.01% 1499
2023
Q1 		$236K Buy
4,892
+1,941
+66% +$94.9K ﹤0.01% 1540
2022
Q4 		$147K Hold
2,951
– – ﹤0.01% 1628
2022
Q3 		$121K Buy
2,951
+1,298
+79% +$60.9K ﹤0.01% 1716
2022
Q2 		$91K Sell
1,653
-1,052
-39% -$44.4K ﹤0.01% 1889
2022
Q1 		$98 Hold
2,705
– – ﹤0.01% 1957
2021
Q4 		$126K Buy
2,705
+2,638
+3,937% +$134K ﹤0.01% 1865
2021
Q3 		$3K Hold
67
– – ﹤0.01% 2610
2021
Q2 		$3K Hold
67
– – ﹤0.01% 2539
2021
Q1 		$2K Hold
67
– – ﹤0.01% 2458
2020
Q4 		$2K Buy
67
+1
+2% +$29 ﹤0.01% 2348
2020
Q3 		$2K Sell
66
-799
-92% -$26.9K ﹤0.01% 2349
2020
Q2 		$37K Buy
+865
New +$33.8K ﹤0.01% 1999

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Macquarie Group's LEGN Position: Q2 2026 in Review

Macquarie Group reduced its Legend Biotech (LEGN) stake by 32% in Q2 2026, selling an estimated $52.4K and leaving 4,155 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Macquarie Group first reported a position in LEGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $414K in Q4 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Macquarie Group held 4,155 shares of Legend Biotech worth $120K as of Q2 2026.
  • Macquarie Group sold 1,941 Legend Biotech shares in Q2 2026, an estimated $52.4K.
  • Legend Biotech made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #800 holding.
  • Macquarie Group first reported a position in Legend Biotech in Q2 2020 and has held it in 25 quarters since.
  • Macquarie Group's Legend Biotech position peaked at $414K in Q4 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.